ENTITY
Indegene

Indegene (INDGN IN)

42
Analysis
Health Care • India
Indegene is an Indian company that offers digitally-led commercialization services to biopharmaceutical and healthcare enterprises globally. It provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. The company is headquartered in Bangalore, India, and was founded in 1998.
more
bullish•Reliance Industries
•11 Jan 2024 10:55

Aequitas 2024 Asia IPO Pipeline - India

In this note, we will take a look at the Asia Pacific IPO pipeline for 2024, following up with India after having looked at Hong Kong earlier.

Logo
770 Views
Share
bullish•Tencent
•01 May 2023 09:10

ECM Weekly (1st May 2023) - ZJLD, Mankind, JD Industrial, JD Property, CPF Global Food, Horizon

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
575 Views
Share
bullish•Rakuten Bank
•23 Apr 2023 07:25

ECM Weekly (23rd Apr 2023) - Rakuten Bank, Merdeka, ZJLD, Mankind, Lalatech, IMotion, Anta, KIT

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
627 Views
Share
bullish•Indegene
•19 Apr 2023 10:51

Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth

Indegene Limited (1864095D IN) is looking to raise about US$400m in its upcoming India IPO. Indegene is a “digital-first” commercialisation firm...

Logo
702 Views
Share
bullish•Indegene
•13 Apr 2023 19:48

Indegene Limited (1864095D IN) Pre-IPO: Enough Head Room For Long-Term Profitable Growth

Indegene, a healthtech company, plans to raise INR32B via IPO to repay debt, fund capex, and pursue acquisitions. Amid secular industry tailwind,...

Logo
716 Views
Share
x